Amylin Pharmaceuticals

Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Currently, Amylin produces three drugs, Symlin and Byetta and Bydureon . Amylin also is working on producing analog of human leptin, metreleptin.

quick facts
NASDAQ symbol:AMLN
Founded:1987
Headquarters:San Diego, California
Annual revenue:$840,110,000
Net income:$-315,400,000
Operating income:$-297,220,000
Market cap:$5,000,000,000
Industries:Biotechnology, Pharmaceutical Preparations

Revenue history for Amylin Pharmaceuticals

RevenueDate
$840,110,000 December 31, 2008
$510,900,000 December 31, 2006
« Prev  Next »

Net income history for Amylin Pharmaceuticals

Net IncomeDate
$-315,400,000 December 31, 2008
« Prev  Next »

Headquarters of Amylin Pharmaceuticals

San Diego
San Diego
Population:1,307,402

San Diego /ˌsæn diːˈeɪɡoʊ/ is the eighth-largest city in the United States and second-largest city in California. The city is located on the coast of the Pacific Ocean in Southern California, immediately adjacent to the Mexican border. The birthplace of...
more

Current Amylin Pharmaceuticals board members

James N Wilson
James N Wilson

James N. Wilson has served Corcept Theraputics as a director and as Chairman of the Board since 1999. In addition, since 2005, Mr. Wilson has been...
more

Divisions of Amylin Pharmaceuticals

Division Name
Amylin Europe ltd
Amylin Investments LLC
Amylin Puerto Rico LLC
Amylin Ohio LLC
« Prev  Next »

Companies in the Same City

Sempra Energy
Sempra Energy
Revenue: $10,758,000,000
Qualcomm
Qualcomm
Revenue: $10,416,000,000
Saic Inc.
Saic Inc.
Revenue: $10,070,000,000
Biogen Idec
Biogen Idec
Revenue: $4,097,510,000
Jack in the Box
Jack in the Box
Revenue: $2,765,600,000
Leap Wireless
Leap Wireless
Revenue: $1,958,860,000
PriceSmart
PriceSmart
Revenue: $1,251,630,000
AMN HEALTHCARE SERVICES INC
AMN HEALTHCARE SERVICES INC
Revenue: $1,217,200,000
ResMed
ResMed
Revenue: $920,740,000
Cubic Corporation
Cubic Corporation
Revenue: $821,400,000
Charlotte Russe Holding, Inc.
Charlotte Russe Holding, Inc.
Revenue: $681,500,000

Frequently Asked Questions

  • Q:
    Which industries does Amylin Pharmaceuticals compete?
  • A:
    The company competes in Biotechnology and Pharmaceutical Preparations.
  • Q:
    What is the stock ticker symbol and stock exchange for Amylin Pharmaceuticals?
  • A:
    The company's symbol is "AMLN" listed on the NASDAQ stock exchange.
Amylin Pharmaceuticals
Top of Page © 2012 Juggle, LLC
All Rights Reserved
Encyclopedia & Reference Resource
Some of the content on this page was provided by other sites, including
Freebase Icon (Amylin Pharmaceuticals) or others licensed under Creative Commons